Clin Psychopharmacol Neurosci.  2015 Dec;13(3):321-323. 10.9758/cpn.2015.13.3.321.

Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report

  • 1Department of Psychiatry, JSS Medical College, Mysore, India.
  • 2Department of Medicine, JSS Medical College, Mysore, India.


Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.


Atomoxetine augment; Treatment resistant panic disorder; Selective norepinephrine reuptake inhibitor
Full Text Links
  • CPN
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: